The intelligence layer for medicine that fits one person.
Data → Prediction → Simulation → Discovery → Better Data
Biafo turns fragmented patient data into predictive models, digital twins, and virtual clinical trials, on a secure, auditable, patient-owned foundation that compounds as it scales.
Healthcare doesn’t lack data. It lacks intelligence infrastructure.
Patient data exists in abundance, trapped across disconnected systems, underused by clinicians, and unreadable to the people it belongs to.
Trials take years and fail more often than they succeed. Treatments are still designed around an average patient who doesn’t exist.
Biafo connects diagnostics, patient data, and predictive modeling into one continuous system, where data improves models, models power simulations, and simulations accelerate discovery.
A system that gets smarter the more it’s used.
Most platforms add features. Biafo closes a loop. Each turn feeds the next, so accuracy compounds and the cost of the next discovery falls.
Clinical records, genomics, imaging, and real-world signals are unified into one trusted, interoperable substrate the source of truth everything is built on.
Patient
Records, genomics, wearables, and real-world data.
AI diagnostics
Pattern recognition across multimodal signals.
Data layer
Secure, compliant, interoperable substrate.
Digital twins
Living models that simulate outcomes first.
Virtual trials
Scalable studies on synthetic + real cohorts.
We crash the twin, not the patient.
A crash-test dummy takes the impact so a person never has to.Your digital twin does the same for medicine. It absorbs every experimental treatment, dose, and "what if," so the real patient only ever meets the answer that already worked.
Choose a candidate therapy
Each is run against the twin, never the patient.
A multi-layer intelligence stack.
Purpose-built for institutional scale. Each layer reinforces the next, and all of them stand on a single foundation of secure, auditable trust.
Virtual trials
Compliant trials run on synthetic and real-world cohorts cutting timelines and cost without compromising regulatory standards.
Data improves models. Models power simulations. Simulations accelerate discovery.
As the dataset grows, Biafo makes drug development faster, cheaper, and lower-risk, with one curve bending down while accuracy bends up.
Every institution that joins adds signal. More signal sharpens the models. Sharper models make twins and virtual trials more predictive, which attracts the next partner. It’s a flywheel with network effects, and it changes the underlying economics of bringing medicine to patients.
Built to be hard to copy, and right on time.
For investors and collaborators evaluating the moat: defensibility here is structural, not incidental.
Data network effects
Each new institution and patient makes the models more accurate for everyone a compounding advantage that's almost impossible for a late entrant to replicate from a standing start.
The moat widens with scaleProprietary methods & patent pathway
The platform is built on novel methods spanning data unification, predictive modeling, and twin simulation, with a patent pathway actively in progress. The public site describes outcomes by design; the methods stay protected.
IP strategy in progressCompliance as a barrier
Governance, auditability, and patient-held consent are engineered into the foundation, not bolted on. That regulatory readiness is a years-long head start most newcomers underestimate.
Trust earned, then defendedWhy now
Foundation models, multimodal data, abundant compute, and regulators warming to digital health have converged for the first time. twin simulation, with a patent pathway actively in progress.
The window is openTrust is the foundation not a feature.
Every data interaction is governed, permissioned, and verifiable by design, meeting the most stringent frameworks from the ground up.
Compliance by design
Architected to operate inside the strictest global frameworks for healthcare data meeting HIPAA, GDPR, and HL7 FHIR from the first line of code, not after deployment.
Full auditability
Every model inference and data-access event is written to an immutable audit trail. Institutions, regulators, and partners can verify the integrity of any action at any time.
Secure data exchange
Permissioned exchange lets providers, researchers, and partners collaborate on intelligence without exposing raw records or surrendering data sovereignty.
Patients hold the keys. Consent is explicit, logged, and revocable.
We take our name from the Biafo Glacier, one of Earth's oldest, longest rivers of ice, holding an unbroken record of everything that came before.
We see the human body the same way. A health story is a living record that should be preserved, carried forward, and owned by no one but the person it belongs to. The institutional platform exists to serve that one human truth.
Build the foundation with us.
Biafo is early, deliberate, and self-funded by conviction. We're opening a limited number of conversations with partners who want to shape this, not just fund it.
Capital with a thesis
A platform play at the intersection of AI, digital twins, and patient-owned data, with structural network effects and a clear path through clinical and regulatory milestones.
Research collaborations
Labs in computational medicine, imaging, genomics, and twin modeling, with opportunities for co-development and data partnerships under NDA, with clear IP terms from day one.
Pilots that prove it
Health systems and life-science partners ready to run focused pilots virtual trials, diagnostic support, and twin-based modeling against real clinical questions.
What you see here is the what. The how (architecture, methods, and models) is shared with qualified partners under NDA.
Frequently asked.
An intelligence layer for medicine: a platform that unifies fragmented patient data and turns it into predictive models, patient-specific digital twins, and virtual clinical trials, on a secure, auditable, patient-owned foundation. Each capability feeds the next, so the system gets sharper as it scales.
Health systems, research institutions, and life-science partners who need predictive intelligence inside regulated environments, and the investors backing that shift. The patient sits at the center: every model serves a real person, and the record stays theirs.
Through permissioned, standards-based connections (HL7 FHIR and related protocols) that normalize clinical records, genomics, imaging, and real-world data into one interoperable substrate, without raw records ever leaving an institution's control. The unification method itself is proprietary.
It reads across multimodal patient signals to surface disease earlier and rank treatment options by predicted response for the individual, supporting clinical judgment, never replacing it.
Permissioned exchange lets providers, researchers, and partners collaborate on intelligence without exposing raw records or surrendering data sovereignty. Every access and inference is written to an immutable audit trail, and consent is explicit, logged, and revocable.
A digital twin is a computational replica of a single patient, accurate enough to stress-test a diagnosis or therapy in silico before anything reaches the person. It's the crash-test dummy for care. The twin absorbs the experiment so the patient meets only the answer.
By running candidate therapies across populations of twins and synthetic cohorts, Biafo can estimate efficacy and risk, identify responders, and pressure-test protocols, compressing timelines and cost while holding regulatory standards. It augments real-world trials; it doesn't bypass them.
We're opening a limited number of collaborations, including data partnerships, co-development, and pilots with academic, clinical, and industry partners under NDA, alongside investment conversations.
Still have questions? Reach the team →